Technical Analysis for PRPO - Precipio, Inc.

Grade Last Price % Change Price Change
grade F 2.33 -3.72% -0.09
PRPO closed down 3.72 percent on Monday, November 11, 2019, on 21 percent of normal volume.

Earnings due: Nov 19

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical PRPO trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Crossed Above 20 DMA Bullish -3.72%
Bollinger Band Squeeze Range Contraction -3.72%
Narrow Range Bar Range Contraction -3.72%
20 DMA Resistance Bearish -2.92%
Bullish Engulfing Bullish -2.92%

Older signals for PRPO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Precipio, Inc., formerly Transgenomic, Inc., is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment. The Company is engaged in the provision of its Multiplexed ICE COLD-PCR (MX-ICP) product to the clinical market, enabling the use of blood and other bodily fluids for diagnosis, monitoring and treatment of cancer. MX-ICP amplifies the ability to detect genetic mutations by approximately 100 to 400 fold. MX-ICP is validated internally on sequencing platforms, including Sanger, Next Gen Sequencing and Digital polymerase chain reaction (PCR). Its laboratory in Omaha, Nebraska is focused on providing genetic analytical services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted.
Biotechnology Cancer Biology Diseases Natural Sciences Treatment Of Cancer Molecular Biology Genomics Molecular Diagnostics Laboratory Services Laboratory Techniques Polymerase Chain Reaction Personalized Medicine
Is PRPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.8
52 Week Low 1.6515
Average Volume 615,267
200-Day Moving Average 3.4074
50-Day Moving Average 2.454
20-Day Moving Average 2.411
10-Day Moving Average 2.414
Average True Range 0.1482
ADX 25.04
+DI 20.5682
-DI 19.1645
Chandelier Exit (Long, 3 ATRs ) 2.1654
Chandelier Exit (Short, 3 ATRs ) 2.6946
Upper Bollinger Band 2.5166
Lower Bollinger Band 2.3054
Percent B (%b) 0.12
BandWidth 8.759851
MACD Line -0.0258
MACD Signal Line -0.0236
MACD Histogram -0.0022
Fundamentals Value
Market Cap 18.92 Million
Num Shares 8.12 Million
EPS -1.74
Price-to-Earnings (P/E) Ratio -1.34
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.54
Resistance 3 (R3) 2.55 2.50 2.51
Resistance 2 (R2) 2.50 2.44 2.49 2.49
Resistance 1 (R1) 2.41 2.41 2.39 2.40 2.48
Pivot Point 2.36 2.36 2.34 2.35 2.36
Support 1 (S1) 2.27 2.30 2.25 2.26 2.18
Support 2 (S2) 2.22 2.27 2.21 2.17
Support 3 (S3) 2.13 2.22 2.16
Support 4 (S4) 2.12